Financhill
Back

Dave Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
29

DAVE
Dave

Last Price:
35.92
Seasonality Move:
-8.61%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
29
Dave (DAVE) is a Sell

Is Dave a Buy, Sell or Hold?

  • The current Dave [DAVE] share price is $35.98. The Score for DAVE is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • DAVE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DAVE Stock Price Chart

What is Dave's stock price today?

  • The Dave share price today is $35.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVE is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

DAVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.55 Sell
Relative Strength Index (14 RSI): 41.22 Sell
Chaikin Money Flow: -148064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.06 - 43.74) Sell
Bollinger Bands (100): (27.5 - 44.8) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

DAVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.57 Sell
20-day SMA: 38.77 Sell
50-day SMA: 42.04 Sell
200-day SMA: 21.84 Buy
8-day EMA: 37.59 Sell
20-day EMA: 38.98 Sell
50-day EMA: 39.48 Sell
200-day EMA: 28.08 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Dave Earnings Growth & DAVE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.07 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.00 per share, and an increase next year of $1.54 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Dave Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):